Home/Filings/4/0001480097-15-000002
4//SEC Filing

AOXING PHARMACEUTICAL COMPANY, INC. 4

Accession 0001480097-15-000002

CIK 0001060426operating

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 2:07 PM ET

Size

4.7 KB

Accession

0001480097-15-000002

Insider Transaction Report

Form 4
Period: 2015-02-05
Chow Wilfred
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2015-02-05$0.32/sh+812,500$260,0001,112,500 total

Issuer

AOXING PHARMACEUTICAL COMPANY, INC.

CIK 0001060426

Entity typeoperating
IncorporatedFL

Related Parties

1
  • filerCIK 0001060426

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 2:07 PM ET
Size
4.7 KB